Discovery Biotech

Triple-negative breast cancer accounts for 15-20% of all breast cancers with a worse prognosis. Learn about the groundbreaking discovery made by Dr. Sanjay Malhotra and his team of researchers in our promising new cancer treatment: discoverybiotech.com/newsroom #drugdiscovery

Study finds a potential new first-line treatment for metastatic #TNBC. Learn more about this discovery and other important developments in metastatic #BreastCancer research covered at the annual meeting of @ASCO: bcrf.org/blog/asco-2025… @BCRFcure #CancerResearch #Oncology

The overexpression of YB-1 has been linked to tumor progression, cell invasion, and treatment resistance in multiple types of cancer. SU056 targets YB-1 and effectively inhibits the growth of #TNBC in preclinical models. Learn more: discoverybiotech.com/newsroom/ #DrugDiscovery

Photo cred: @theNCI

Approximately 13% of women will be diagnosed with #BreastCancer during their lifetime. Researchers work to advance our understanding of how to prevent, detect, and treat this disease that affects so many. Learn about the latest #BreastCancerResearch: cancer.gov/types/breast/r…

Honored to connect with Nobel Laureate, Dr. Randy Schekman, at the 2025 Stanford Drug Discovery Symposium (SDDS). Dr. Schekman received the Nobel Prize for discovering how genes regulate visicle traffic in cells. Learn more: mcb.berkeley.edu/faculty/CDB/sc… #SDDS2025 #DrugDiscovery

Join us at the 2025 Stanford Drug Discovery Symposium (SDDS) this April 28-29th, 2025. Connect with other members of the #DrugDiscovery community and grow your network. Virtual registration is available through April 29th. Register now: med.stanford.edu/content/sm/cvi… #SDDS2025

Dr. Nancy Lin's research focuses on advancing new strategies to prevent and treat #BreastCancer metastasis. She led clinical trials that expanded treatment options for people with breast cancer brain metastases. Learn more: bcrf.org/researchers/na… @BCRFcure @DanaFarber

Join us on Wednesday, April 9, 2025, for the first Oregon Drug Discovery Symposium (ODDS) at Oregon Health & Science University (OHSU). Virtual attendance is FREE with registration. Register now: ohsu.edu/knight-cancer-… #ODDS2025 #DrugDiscovery #Biotech @OHSUNews

@MSKCancerCenter Photo Cred: Karsten Moran

Dr. Maria Jasin's DNA repair research paved the way for other discoveries, including CRISPR gene editing. Her studies continue to explore the development of BRCA-related #BreastCancer and identifying targeted prevention strategies. Learn more: mskcc.org/news/big-break…

Photo cred: @BCRFcure

Dr. Mina Bissell spearheaded research into the role of tissue architecture and the cellular microenvironment in cancer. Her research highlighted the crucial role of the tumor microenvironment in #BreastCancer biology and #CancerTreatment. Learn more: bcrf.org/blog/bcrf-inve…

Dr. Jane C. Wright pioneered research into the treatment of #BreastCancer with the drug methotrexate. Known as the “Godmother of Chemotherapy,” her work has saved millions of lives. Learn more: nationalbreastcancer.org/blog/dr-jane-c… @NBCF #WomenInHistory #CancerResearch

#BreastCancer is the second leading cause of death from cancer in American women. Preventative measures can be taken to reduce the risk of breast cancer, such as exercising regularly and lowering alcohol intake. Learn more: cancer.gov/types/breast/p… @theNCI #CancerPreventionMonth

The 2025 Stanford Drug Discovery Symposium (SDDS) is open for registration. While anticipating this year’s event, revisit SDDS 2024's live stream recordings. med.stanford.edu/cvi/events/202… Register for #SDDS2025: med.stanford.edu/content/sm/cvi… #DrugDiscovery

We are proud sponsors of the 2025 Stanford Drug Symposium (SDDS). Last year’s symposium was a pleasure to be part of, and we look forward to connecting with other members of the #DrugDiscovery community again. Learn more about #SDDS2025: med.stanford.edu/content/sm/cvi…

Over 13,000 women in the United States are diagnosed with #CervicalCancer each year, and more than 4,000 of these women pass away. Learn more about cervical cancer prevention: nccc-online.org/understanding-… @StopHPVCancer #CervicalCancerAwareness

Photo cred: @MDAndersonNews

Triple-negative breast cancer (TNBC) has different receptors from most types of #BreastCancer and a high rate of recurrence. #TNBC lacks the receptors doctors typically target when treating breast cancer and cannot be treated by targeting them. Learn more: mdanderson.org/cancerwise/tri…

We're a clinical-stage biotech company focused on translating science into high-impact medical solutions. Our initial pharmaceutical offering, SU056, targets YB-1 and effectively inhibits the growth of #TNBC in preclinical models. Learn more: discoverybiotech.com/newsroom/